Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children.
about
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika VirusInfections and Brain DevelopmentCytomegalovirus in pregnancy: to screen or not to screen.Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and preventionImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelPost-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns.Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infectionHuman cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placentaPreliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection.The "silent" global burden of congenital cytomegalovirus.CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.Cytomegalovirus in the neonate: immune correlates of infection and protectionAntibody inhibition of human cytomegalovirus spread in epithelial cell culturesFunctional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope proteinPrimary Human Cytomegalovirus (HCMV) Infection in Pregnancy.HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.Intrauterine growth restriction caused by underlying congenital cytomegalovirus infectionTwin pregnancy and congenital cytomegalovirus: case report and review.Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.Optimum treatment of congenital cytomegalovirus infection.Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.Maternal immune correlates of protection against placental transmission of cytomegalovirus.Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.Preventing Congenital Cytomegalovirus Infection.Study of human cytomegalovirus replication in body fluids, placental infection, and miscarriage during the first trimester of pregnancy.Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight.Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirusFetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy.IUGR and congenital cytomegalovirus infection.Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infectionLarge-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
P2860
Q26247258-A2F46607-1E31-4A56-B49A-885F201A169AQ26778598-7621623D-41E6-4BE5-AB86-B9F163FD46C2Q26851794-AEDEA215-2CCD-41BB-A715-99EE1E102F7DQ27024030-C3958AC9-9AF7-43AB-A24D-D13D5BEBD2DCQ27026924-14EBA33E-B395-45C7-8CB6-D8A50E3E32DCQ30491681-5CD1A82B-47FA-4AA4-AD5E-765130556897Q33877783-9D01BE16-01C4-46ED-BD5F-B1F71A26D7F3Q34652466-6A36743F-DFEB-486B-BB3A-13B25C6F140DQ35488673-9C2EBEA9-6BCD-4F8A-A8A2-9385C85984F6Q36505218-0E2DCC8C-565D-410E-8FAD-C5AD2B86E5F0Q36558293-DEF4A5E6-2470-4810-BC00-4AAC33CD7509Q37014401-D464D028-EB6C-42C8-BB2B-1632D35EAE97Q37140130-40728E5A-7BD1-4D26-91A0-1018A035F162Q37174327-194BAE76-6B0C-46B8-A4E1-FAB8B3B67505Q37519151-CD77EC2A-6A66-4C7A-97F2-BA89BC23A2ACQ37656015-35B24179-914B-495A-81FB-61D18E530B8EQ37673149-B6C95E01-EAE8-4E81-89B3-F20D066F8932Q37719762-1EBE1AED-FC77-4A10-B7F3-5431390571A2Q38058345-0A13A9D9-3886-4CFA-9B3E-F2400607C369Q38260298-9ECD085A-8CBD-4B25-B67D-520A23212891Q38708710-9AEB969E-608D-430B-AE39-8E0F4AADC81FQ38797872-A9EC43CF-9398-434B-88BE-03ABB48D45DDQ39051240-68668FA0-7F73-4DFA-B196-BC0306E38D1EQ39272221-FDF0FF4E-026B-4462-8705-983D009FC79DQ40059344-9F0FE2CA-F51A-4927-9170-DCCB21642E74Q40086042-FE86D1BB-079F-4006-B471-FA252571A538Q41454863-E0AE2C4D-219A-41F6-B159-4334ED36389AQ42222597-5A3C779D-8BBC-42AC-A732-73ED6DC7E000Q42572343-6ADF9EFF-D217-4ED3-B5A2-03746A12D75EQ44735402-C9A1104F-8513-4AD7-9B41-469786C970FAQ46796623-BED22215-877F-4A1C-85D4-D10472BB1627Q50087895-9DE64C1D-84F5-48D6-B53A-467F2B752B9BQ54956176-FF1AF47A-689D-426E-93E0-4B9E5A023C44Q57072187-8C94A3D1-82EC-46CE-8A99-44722736E17AQ58738833-1282682E-CC2A-4C8E-915A-5819544FFE2F
P2860
Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@ast
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@en
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@nl
type
label
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@ast
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@en
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@nl
prefLabel
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@ast
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@en
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@nl
P2093
P2860
P356
P1476
Immunoglobulin therapy of feta ...... dy of the outcome in children.
@en
P2093
Eleonora Coclite
Giovanni Nigro
Giustino Parruti
Ilaria Pezone
Maurizio M Anceschi
Stuart P Adler
P2860
P304
P356
10.1093/INFDIS/JIR718
P407
P577
2011-12-02T00:00:00Z